These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30668189)

  • 1. Efficacy and safety of high-intensity focused ultrasound ablation for hepatocellular carcinoma by changing the acoustic environment: microbubble contrast agent (SonoVue) and transcatheter arterial chemoembolization.
    Huang L; Zhou K; Zhang J; Ma Y; Yang W; Ran L; Jin C; Dimitrov DD; Zhu H
    Int J Hyperthermia; 2019; 36(1):244-252. PubMed ID: 30668189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using microbubble sonographic contrast agent to enhance the effect of high intensity focused ultrasound for the treatment of uterine fibroids.
    Isern J; Pessarrodona A; Rodriguez J; Vallejo E; Gimenez N; Cassadó J; De Marco JA; Pedrerol A
    Ultrason Sonochem; 2015 Nov; 27():688-693. PubMed ID: 26113390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects and prognostic factors in high-intensity focused ultrasound combined with chemoembolisation for larger hepatocellular carcinoma.
    Li C; Zhang W; Zhang R; Zhang L; Wu P; Zhang F
    Eur J Cancer; 2010 Sep; 46(13):2513-21. PubMed ID: 20663659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of texture analysis based on enhanced MRI for predicting an early therapeutic response to transcatheter arterial chemoembolisation combined with high-intensity focused ultrasound treatment in hepatocellular carcinoma.
    Yu JY; Zhang HP; Tang ZY; Zhou J; He XJ; Liu YY; Liu XJ; Guo DJ
    Clin Radiol; 2018 Aug; 73(8):758.e9-758.e18. PubMed ID: 29804627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial.
    Jiang N; Xie B; Zhang X; He M; Li K; Bai J; Wang Z; He J; Zhang L
    Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1321-8. PubMed ID: 24549267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Contrast-Enhanced Ultrasound for Early Therapeutic Evaluation of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization.
    Watanabe Y; Ogawa M; Kumagawa M; Hirayama M; Miura T; Matsumoto N; Nakagawara H; Yamamoto T; Moriyama M
    J Ultrasound Med; 2020 Mar; 39(3):431-440. PubMed ID: 31436341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing ablation effects of a microbubble contrast agent on high-intensity focused ultrasound: an experimental and clinical study.
    Cheng C; Xiao Z; Huang G; Zhang L; Bai J
    BJOG; 2017 Aug; 124 Suppl 3():78-86. PubMed ID: 28856858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy--preliminary observations.
    Kim J; Chung DJ; Jung SE; Cho SH; Hahn ST; Lee JM
    Br J Radiol; 2012 Oct; 85(1018):e940-6. PubMed ID: 22553305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
    Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
    Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of a microbubble-enhancing contrast ("SonoVue") in treatment of uterine fibroids with high intensity focused ultrasound: a retrospective study.
    Peng S; Xiong Y; Li K; He M; Deng Y; Chen L; Zou M; Chen W; Wang Z; He J; Zhang L
    Eur J Radiol; 2012 Dec; 81(12):3832-8. PubMed ID: 22613505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The quantitative analysis of MR dynamic contrast-enhangced imaging on efficacy and prognosis of transcatheter arterial chemoembolization on hepatocellular carcinoma].
    Ma XH; Wang S; Zhao XM; Ouyang H; Wang M; Zhu YJ; Zhu Z; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):689-694. PubMed ID: 28926899
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma].
    Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.
    Chok KS; Cheung TT; Lo RC; Chu FS; Tsang SH; Chan AC; Sharr WW; Fung JY; Dai WC; Chan SC; Fan ST; Lo CM
    Liver Transpl; 2014 Aug; 20(8):912-21. PubMed ID: 24753206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative MRI features and clinical laboratory indicators for predicting the early therapeutic response of hepatocellular carcinoma to transcatheter arterial chemoembolization combined with High-intensity focused ultrasound treatment.
    Zhang H; He X; Yu J; Song W; Liu X; Liu Y; Zhou J; Guo D
    Br J Radiol; 2019 Jul; 92(1099):20190073. PubMed ID: 31166700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma.
    Park KH; Kwon SH; Lee YS; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ
    Clin Mol Hepatol; 2015 Jun; 21(2):158-64. PubMed ID: 26157753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
    Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
    Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography.
    Fujita T; Ito K; Tanabe M; Yamatogi S; Sasai H; Matsunaga N
    J Vasc Interv Radiol; 2008 Mar; 19(3):333-41. PubMed ID: 18295691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.